<DOC>
	<DOCNO>NCT00002027</DOCNO>
	<brief_summary>To evaluate safety efficacy diclazuril capsule compare placebo capsule treatment cryptosporidial related diarrhea AIDS patient . Treatment efficacy base drug 's clinical result anti-protozoan effect . Safety assess occurrence side effect report patient visits frequent monitoring hematology , biochemistry , urinalysis .</brief_summary>
	<brief_title>Protocol For Treatment Cryptosporidiosis AIDS Patients With Diclazuril ( R64,433 )</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Cryptosporidiosis</mesh_term>
	<mesh_term>Diclazuril</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Patients require antidiarrheal medication must receive one antidiarrheal medication , loperamide , least 7 day prior study entry . Dose loperamide increase study . Aerosolized pentamidine . Ganciclovir cytomegalovirus ( CMV ) retinitis patient must stable least 4 week prior study entry . Zidovudine ( AZT ) . Nystatin oropharyngeal infection take within 2 hour diclazuril . Patients must : Diagnosis AIDS confirm HIV positive Western blot AIDS define diagnosis , CDC define AIDS . Stool specimens positive cryptosporidium oocysts . Given write informed consent purpose nature study , well possible drugrelated adverse effect , explain . Ability return subsequent applicable visit day 8 , 15 , 21 , , necessary , 28 . Prior Medication : Allowed : Aerosolized pentamidine . Loperamide . Ganciclovir cytomegalovirus ( CMV ) retinitis . Exclusion Criteria Coexisting Condition : Patients follow exclude : Diagnosis cryptosporidiosis le 4 week prior study entry , unless patient diagnose AIDS 4 week . Other treatable enteric pathogen include Clostridia must treat eradicate prior study entry . Inability swallow capsule . Uncontrolled vomiting . Concurrent Medication : Excluded : Trimethoprim/sulfamethoxazole ( Bactrim ) . Ganciclovir reason except cytomegalovirus ( CMV ) retinitis . Other antibiotic . Other antiprotozoal drug . Antifungal drug nystatin . Amphotericin B . Other investigational drug . Patients follow exclude : Diagnosis cryptosporidiosis le 4 week prior study entry , unless patient diagnose AIDS 4 week . Inability swallow capsule . Uncontrolled vomiting . Life expectancy &lt; 28 day . Can depend upon follow instruction investigator . Participation investigational study within 15 day study entry . Prior Medication : Excluded within 15 day study entry : Another investigational drug device ( except aerosolize pentamidine ) . Prior Treatment : Excluded within 15 day study entry : Participation investigational study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 1990</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Cryptosporidiosis</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>diclazuril</keyword>
	<keyword>Coccidiostats</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>